Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines.
Drane D, Gittleson C, Boyle J, Maraskovsky E. Drane D, et al. Among authors: maraskovsky e. Expert Rev Vaccines. 2007 Oct;6(5):761-72. doi: 10.1586/14760584.6.5.761. Expert Rev Vaccines. 2007. PMID: 17931156 Free article. Review.
Combination of adjuvants: the future of vaccine design.
Mount A, Koernig S, Silva A, Drane D, Maraskovsky E, Morelli AB. Mount A, et al. Among authors: maraskovsky e. Expert Rev Vaccines. 2013 Jul;12(7):733-46. doi: 10.1586/14760584.2013.811185. Expert Rev Vaccines. 2013. PMID: 23885819 Free article. Review.
NY-ESO-1 protein formulated in ISCOMATRIX adjuvant is a potent anticancer vaccine inducing both humoral and CD8+ t-cell-mediated immunity and protection against NY-ESO-1+ tumors.
Maraskovsky E, Sjölander S, Drane DP, Schnurr M, Le TT, Mateo L, Luft T, Masterman KA, Tai TY, Chen Q, Green S, Sjölander A, Pearse MJ, Lemonnier FA, Chen W, Cebon J, Suhrbier A. Maraskovsky E, et al. Clin Cancer Res. 2004 Apr 15;10(8):2879-90. doi: 10.1158/1078-0432.ccr-03-0245. Clin Cancer Res. 2004. PMID: 15102697
Ex vivo restimulation of human PBMC expands a CD3+CD4-CD8- γδ+ T cell population that can confound the evaluation of CD4 and CD8 T cell responses to vaccination.
Sedgmen BJ, Papalia L, Wang L, Dyson AR, McCallum HA, Simson CM, Pearse MJ, Maraskovsky E, Hung D, Eomois PP, Hartel G, Barnden MJ, Rockman SP. Sedgmen BJ, et al. Among authors: maraskovsky e. Clin Dev Immunol. 2013;2013:186420. doi: 10.1155/2013/186420. Epub 2013 Aug 26. Clin Dev Immunol. 2013. PMID: 24066003 Free PMC article.
ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway.
Wilson NS, Yang B, Morelli AB, Koernig S, Yang A, Loeser S, Airey D, Provan L, Hass P, Braley H, Couto S, Drane D, Boyle J, Belz GT, Ashkenazi A, Maraskovsky E. Wilson NS, et al. Among authors: maraskovsky e. Immunol Cell Biol. 2012 May;90(5):540-52. doi: 10.1038/icb.2011.71. Epub 2011 Sep 6. Immunol Cell Biol. 2012. PMID: 21894173 Free PMC article.
Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.
Maraskovsky E, Rockman S, Dyson A, Koernig S, Becher D, Morelli AB, Barnden M, Camuglia S, Bodle J, Vandenberg K, Wang IM, Cristescu R, Loboda A, Citron M, Fontenot J, Hung D, Schoofs P, Pearse M. Maraskovsky E, et al. Vaccine. 2012 Dec 7;30(51):7400-6. doi: 10.1016/j.vaccine.2012.09.083. Epub 2012 Oct 9. Vaccine. 2012. PMID: 23063831
112 results